News
Moncton Institutions on Cutting Edge of Medical Research
Atlantic Cancer Research Institute and Université de Moncton strengthening New Brunswick’s bioscience sector
April 18, 2019 – Moncton, NB – Atlantic Canada Opportunities Agency
Developing new technology and seeking healthcare innovations to offer Canadians better access to medical treatment are key to improving lives, advancing standards of care and encouraging prosperity.
Moncton-based Atlantic Cancer Research Institute (ACRI) and the Université de Moncton (U de M) are undertaking projects to bring cutting-edge disease screening technology and research platforms one step closer to commercialization, and to establish the New Brunswick Centre for Precision Medicine (NBCPM).
The Government of Canada, through the Atlantic Canada Opportunities Agency (ACOA), is providing non-repayable contributions totalling more than $4.9 million for these projects, while the New Brunswick Innovation Foundation (NBIF) is contributing $374,000 to the U de M project.
The Honourable Ginette Petitpas Taylor, Minister of Health and Member of Parliament for Moncton-Riverview-Dieppe, on behalf of the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development and Minister responsible for ACOA, along with the Honourable Dominic LeBlanc, Minister of Intergovernmental and Northern Affairs and Internal Trade and Member of Parliament for Beauséjour, ACRI officials, and U de M representatives made the announcement today.
Economic growth and the creation of good jobs for Atlantic Canadians require innovation and diversification. Support for these projects is one way the Government of Canada is growing the innovation economy by working to sustain strategic clusters, and enhance the development and reach of business accelerators and incubators. Projects like these also contribute to the Atlantic Growth Strategy outcome of long-term economic prosperity in the region.
